Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with breast cancer that is hormone receptor-positive (HR+) and HER2-negative, and whose cancer has either come back or spread to other parts of the body, confirmed by a tissue or cell sample test.
- People whose cancer has a specific gene change called a PIK3CA mutation, confirmed by a laboratory test on a tissue or blood sample.
- People for whom complete medical records, scan results, lab results, and follow-up information are available and traceable from the start of treatment.
- People who have already started a treatment regimen including a drug called Inavolisib combined with hormone-based therapy, with or without another type of drug called a CDK4/6 inhibitor, as part of their regular medical care — and for whom full details of that treatment are on record.
- People who have given their consent to take part in this observational study, where this is required by the ethics committee at the treating centre.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are currently taking part in another clinical trial that involves an active treatment or intervention at the time of enrolment.
- People who have another active cancer at the same time that requires its own systemic treatment, or for whom key medical data needed to assess outcomes is missing.
- People who have a condition — such as a mental health condition, social circumstances, or geographic location — that the trial investigator considers would make regular follow-up difficult or unlikely.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13691534938
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Real-World Progression-Free Survival (rwPFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.